These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
199 related articles for article (PubMed ID: 19811812)
21. Ratio of controller to total asthma medications: determinants of the measure. Broder MS; Gutierrez B; Chang E; Meddis D; Schatz M Am J Manag Care; 2010 Mar; 16(3):170-8. PubMed ID: 20225912 [TBL] [Abstract][Full Text] [Related]
22. The frequency of asthma exacerbations and healthcare utilization in patients with asthma from the UK and USA. Suruki RY; Daugherty JB; Boudiaf N; Albers FC BMC Pulm Med; 2017 Apr; 17(1):74. PubMed ID: 28449686 [TBL] [Abstract][Full Text] [Related]
23. Tailored interventions based on sputum eosinophils versus clinical symptoms for asthma in children and adults. Petsky HL; Li A; Chang AB Cochrane Database Syst Rev; 2017 Aug; 8(8):CD005603. PubMed ID: 28837221 [TBL] [Abstract][Full Text] [Related]
24. Composite type-2 biomarker strategy versus a symptom-risk-based algorithm to adjust corticosteroid dose in patients with severe asthma: a multicentre, single-blind, parallel group, randomised controlled trial. Heaney LG; Busby J; Hanratty CE; Djukanovic R; Woodcock A; Walker SM; Hardman TC; Arron JR; Choy DF; Bradding P; Brightling CE; Chaudhuri R; Cowan DC; Mansur AH; Fowler SJ; Niven RM; Howarth PH; Lordan JL; Menzies-Gow A; Harrison TW; Robinson DS; Holweg CTJ; Matthews JG; Pavord ID; Lancet Respir Med; 2021 Jan; 9(1):57-68. PubMed ID: 32916135 [TBL] [Abstract][Full Text] [Related]
25. Risk Factors for Asthma Exacerbation and Treatment Failure in Adults and Adolescents with Well-controlled Asthma during Continuation and Step-Down Therapy. DiMango E; Rogers L; Reibman J; Gerald LB; Brown M; Sugar EA; Henderson R; Holbrook JT Ann Am Thorac Soc; 2018 Aug; 15(8):955-961. PubMed ID: 29863899 [TBL] [Abstract][Full Text] [Related]
26. Impact of adherence to treatment with fluticasone propionate/salmeterol in asthma patients. Ismaila A; Corriveau D; Vaillancourt J; Parsons D; Stanford R; Su Z; Sampalis JS Curr Med Res Opin; 2014 Jul; 30(7):1417-25. PubMed ID: 24666139 [TBL] [Abstract][Full Text] [Related]
27. Incidence, risk factors and re-exacerbation rate of severe asthma exacerbations in a multinational, multidatabase pediatric cohort study. Engelkes M; Baan EJ; de Ridder MAJ; Svensson E; Prieto-Alhambra D; Lapi F; Giaquinto C; Picelli G; Boudiaf N; Albers F; Evitt LA; Cockle S; Bradford E; Van Dyke MK; Suruki R; Rijnbeek P; Sturkenboom MCJM; Janssens HM; Verhamme KMC Pediatr Allergy Immunol; 2020 Jul; 31(5):496-505. PubMed ID: 32115766 [TBL] [Abstract][Full Text] [Related]
28. Resource utilization in asthma: combined fluticasone propionate/salmeterol compared with inhaled corticosteroids. Friedman HS; Yawn BP Curr Med Res Opin; 2007 Feb; 23(2):427-34. PubMed ID: 17288696 [TBL] [Abstract][Full Text] [Related]
29. Impact of mepolizumab on exacerbations in severe asthma: Results from a U.S. insurance claims data base. Ortega H; Hahn B; Bogart M; Bell CF; Bancroft T; Chastek B; Llanos JP Allergy Asthma Proc; 2020 Sep; 41(5):341-347. PubMed ID: 32867888 [No Abstract] [Full Text] [Related]
30. Association between previous health care use and initiation of inhaled corticosteroid and long-acting beta2-adrenergic agonist combination therapy among US patients with asthma. Blanchette CM; Culler SD; Ershoff D; Gutierrez B Clin Ther; 2009 Nov; 31(11):2574-83. PubMed ID: 20110003 [TBL] [Abstract][Full Text] [Related]
31. Predictive factors for moderate or severe exacerbations in asthma patients receiving outpatient care. Gutiérrez FJÁ; Galván MF; Gallardo JFM; Mancera MB; Romero BR; Falcón AR BMC Pulm Med; 2017 May; 17(1):77. PubMed ID: 28464895 [TBL] [Abstract][Full Text] [Related]
32. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2013 Feb; 2013(2):CD009611. PubMed ID: 23450606 [TBL] [Abstract][Full Text] [Related]
33. Inadequate follow-up controller medications among patients with asthma who visit the emergency department. Cydulka RK; Tamayo-Sarver JH; Wolf C; Herrick E; Gress S Ann Emerg Med; 2005 Oct; 46(4):316-22. PubMed ID: 16187464 [TBL] [Abstract][Full Text] [Related]
34. Impact of asthma exacerbations and asthma triggers on asthma-related quality of life in patients with severe or difficult-to-treat asthma. Luskin AT; Chipps BE; Rasouliyan L; Miller DP; Haselkorn T; Dorenbaum A J Allergy Clin Immunol Pract; 2014; 2(5):544-52.e1-2. PubMed ID: 25213047 [TBL] [Abstract][Full Text] [Related]
36. Preseasonal treatment with either omalizumab or an inhaled corticosteroid boost to prevent fall asthma exacerbations. Teach SJ; Gill MA; Togias A; Sorkness CA; Arbes SJ; Calatroni A; Wildfire JJ; Gergen PJ; Cohen RT; Pongracic JA; Kercsmar CM; Khurana Hershey GK; Gruchalla RS; Liu AH; Zoratti EM; Kattan M; Grindle KA; Gern JE; Busse WW; Szefler SJ J Allergy Clin Immunol; 2015 Dec; 136(6):1476-1485. PubMed ID: 26518090 [TBL] [Abstract][Full Text] [Related]
37. High blood eosinophil count is a risk factor for future asthma exacerbations in adult persistent asthma. Zeiger RS; Schatz M; Li Q; Chen W; Khatry DB; Gossage D; Tran TN J Allergy Clin Immunol Pract; 2014; 2(6):741-50. PubMed ID: 25439366 [TBL] [Abstract][Full Text] [Related]
38. Intermittent versus daily inhaled corticosteroids for persistent asthma in children and adults. Chauhan BF; Chartrand C; Ducharme FM Cochrane Database Syst Rev; 2012 Dec; 12():CD009611. PubMed ID: 23235678 [TBL] [Abstract][Full Text] [Related]
39. Pediatric acute asthma exacerbations: Evaluation and management from emergency department to intensive care unit. Pardue Jones B; Fleming GM; Otillio JK; Asokan I; Arnold DH J Asthma; 2016 Aug; 53(6):607-17. PubMed ID: 27116362 [TBL] [Abstract][Full Text] [Related]